Computational Drug Discovery Market

Global Computational Drug Discovery Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: May-2021 | Id: MACRC-63627 | Geographical Scope: Global | Publisher: HNY Research

The global Computational Drug Discovery market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
AMRI
BioDuro
Evotec
Charles River
AstraZeneca
Schrödinger
Aris Pharmaceuticals
GVK Biosciences
Bayers
BOC Sciences
ChemDiv
Pharmaron
RTI International
XRQTC

By Types:
Structure-based Drug Design (SBDD)
Ligand-based Drug Design (LBDD)
Sequence-based Approaches

By Applications:
Oncological Disorders
Neurological Disorders
Immunological Disorders
Infectious Diseases
Others

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Computational Drug Discovery Revenue 1.5 Market Analysis by Type 1.5.1 Global Computational Drug Discovery Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Structure-based Drug Design (SBDD) 1.5.3 Ligand-based Drug Design (LBDD) 1.5.4 Sequence-based Approaches 1.6 Market by Application 1.6.1 Global Computational Drug Discovery Market Share by Application: 2022-2027 1.6.2 Oncological Disorders 1.6.3 Neurological Disorders 1.6.4 Immunological Disorders 1.6.5 Infectious Diseases 1.6.6 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Computational Drug Discovery Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Computational Drug Discovery Market Players Profiles 3.1 AMRI 3.1.1 AMRI Company Profile 3.1.2 AMRI Computational Drug Discovery Product Specification 3.1.3 AMRI Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 BioDuro 3.2.1 BioDuro Company Profile 3.2.2 BioDuro Computational Drug Discovery Product Specification 3.2.3 BioDuro Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Evotec 3.3.1 Evotec Company Profile 3.3.2 Evotec Computational Drug Discovery Product Specification 3.3.3 Evotec Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Charles River 3.4.1 Charles River Company Profile 3.4.2 Charles River Computational Drug Discovery Product Specification 3.4.3 Charles River Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 AstraZeneca 3.5.1 AstraZeneca Company Profile 3.5.2 AstraZeneca Computational Drug Discovery Product Specification 3.5.3 AstraZeneca Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Schrödinger 3.6.1 Schrödinger Company Profile 3.6.2 Schrödinger Computational Drug Discovery Product Specification 3.6.3 Schrödinger Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Aris Pharmaceuticals 3.7.1 Aris Pharmaceuticals Company Profile 3.7.2 Aris Pharmaceuticals Computational Drug Discovery Product Specification 3.7.3 Aris Pharmaceuticals Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 GVK Biosciences 3.8.1 GVK Biosciences Company Profile 3.8.2 GVK Biosciences Computational Drug Discovery Product Specification 3.8.3 GVK Biosciences Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Bayers 3.9.1 Bayers Company Profile 3.9.2 Bayers Computational Drug Discovery Product Specification 3.9.3 Bayers Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 BOC Sciences 3.10.1 BOC Sciences Company Profile 3.10.2 BOC Sciences Computational Drug Discovery Product Specification 3.10.3 BOC Sciences Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 ChemDiv 3.11.1 ChemDiv Company Profile 3.11.2 ChemDiv Computational Drug Discovery Product Specification 3.11.3 ChemDiv Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Pharmaron 3.12.1 Pharmaron Company Profile 3.12.2 Pharmaron Computational Drug Discovery Product Specification 3.12.3 Pharmaron Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 RTI International 3.13.1 RTI International Company Profile 3.13.2 RTI International Computational Drug Discovery Product Specification 3.13.3 RTI International Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 XRQTC 3.14.1 XRQTC Company Profile 3.14.2 XRQTC Computational Drug Discovery Product Specification 3.14.3 XRQTC Computational Drug Discovery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Computational Drug Discovery Market Competition by Market Players 4.1 Global Computational Drug Discovery Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Computational Drug Discovery Revenue Market Share by Market Players (2016-2021) 4.3 Global Computational Drug Discovery Average Price by Market Players (2016-2021) 5 Global Computational Drug Discovery Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Computational Drug Discovery Market Size (2016-2021) 5.1.2 Computational Drug Discovery Key Players in North America (2016-2021) 5.1.3 North America Computational Drug Discovery Market Size by Type (2016-2021) 5.1.4 North America Computational Drug Discovery Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Computational Drug Discovery Market Size (2016-2021) 5.2.2 Computational Drug Discovery Key Players in East Asia (2016-2021) 5.2.3 East Asia Computational Drug Discovery Market Size by Type (2016-2021) 5.2.4 East Asia Computational Drug Discovery Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Computational Drug Discovery Market Size (2016-2021) 5.3.2 Computational Drug Discovery Key Players in Europe (2016-2021) 5.3.3 Europe Computational Drug Discovery Market Size by Type (2016-2021) 5.3.4 Europe Computational Drug Discovery Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Computational Drug Discovery Market Size (2016-2021) 5.4.2 Computational Drug Discovery Key Players in South Asia (2016-2021) 5.4.3 South Asia Computational Drug Discovery Market Size by Type (2016-2021) 5.4.4 South Asia Computational Drug Discovery Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Computational Drug Discovery Market Size (2016-2021) 5.5.2 Computational Drug Discovery Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Computational Drug Discovery Market Size by Type (2016-2021) 5.5.4 Southeast Asia Computational Drug Discovery Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Computational Drug Discovery Market Size (2016-2021) 5.6.2 Computational Drug Discovery Key Players in Middle East (2016-2021) 5.6.3 Middle East Computational Drug Discovery Market Size by Type (2016-2021) 5.6.4 Middle East Computational Drug Discovery Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Computational Drug Discovery Market Size (2016-2021) 5.7.2 Computational Drug Discovery Key Players in Africa (2016-2021) 5.7.3 Africa Computational Drug Discovery Market Size by Type (2016-2021) 5.7.4 Africa Computational Drug Discovery Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Computational Drug Discovery Market Size (2016-2021) 5.8.2 Computational Drug Discovery Key Players in Oceania (2016-2021) 5.8.3 Oceania Computational Drug Discovery Market Size by Type (2016-2021) 5.8.4 Oceania Computational Drug Discovery Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Computational Drug Discovery Market Size (2016-2021) 5.9.2 Computational Drug Discovery Key Players in South America (2016-2021) 5.9.3 South America Computational Drug Discovery Market Size by Type (2016-2021) 5.9.4 South America Computational Drug Discovery Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Computational Drug Discovery Market Size (2016-2021) 5.10.2 Computational Drug Discovery Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Computational Drug Discovery Market Size by Type (2016-2021) 5.10.4 Rest of the World Computational Drug Discovery Market Size by Application (2016-2021) 6 Global Computational Drug Discovery Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Computational Drug Discovery Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Computational Drug Discovery Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Computational Drug Discovery Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Computational Drug Discovery Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Computational Drug Discovery Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Computational Drug Discovery Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Computational Drug Discovery Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Computational Drug Discovery Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Computational Drug Discovery Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Computational Drug Discovery Consumption by Countries 7 Global Computational Drug Discovery Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Computational Drug Discovery (2022-2027) 7.2 Global Forecasted Revenue of Computational Drug Discovery (2022-2027) 7.3 Global Forecasted Price of Computational Drug Discovery (2022-2027) 7.4 Global Forecasted Production of Computational Drug Discovery by Region (2022-2027) 7.4.1 North America Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.3 Europe Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.7 Africa Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.9 South America Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Computational Drug Discovery Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Computational Drug Discovery by Application (2022-2027) 8 Global Computational Drug Discovery Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Computational Drug Discovery by Country 8.2 East Asia Market Forecasted Consumption of Computational Drug Discovery by Country 8.3 Europe Market Forecasted Consumption of Computational Drug Discovery by Countriy 8.4 South Asia Forecasted Consumption of Computational Drug Discovery by Country 8.5 Southeast Asia Forecasted Consumption of Computational Drug Discovery by Country 8.6 Middle East Forecasted Consumption of Computational Drug Discovery by Country 8.7 Africa Forecasted Consumption of Computational Drug Discovery by Country 8.8 Oceania Forecasted Consumption of Computational Drug Discovery by Country 8.9 South America Forecasted Consumption of Computational Drug Discovery by Country 8.10 Rest of the world Forecasted Consumption of Computational Drug Discovery by Country 9 Global Computational Drug Discovery Sales by Type (2016-2027) 9.1 Global Computational Drug Discovery Historic Market Size by Type (2016-2021) 9.2 Global Computational Drug Discovery Forecasted Market Size by Type (2022-2027) 10 Global Computational Drug Discovery Consumption by Application (2016-2027) 10.1 Global Computational Drug Discovery Historic Market Size by Application (2016-2021) 10.2 Global Computational Drug Discovery Forecasted Market Size by Application (2022-2027) 11 Global Computational Drug Discovery Manufacturing Cost Analysis 11.1 Computational Drug Discovery Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Computational Drug Discovery 12 Global Computational Drug Discovery Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Computational Drug Discovery Distributors List 12.3 Computational Drug Discovery Customers 12.4 Computational Drug Discovery Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00